Citation Impact
Citing Papers
Cloning of a human parvovirus by molecular screening of respiratory tract samples
2005 Standout
Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
2001
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules
2004 StandoutNobel
Detection and activation of human Vα24+ natural killer T cells using α-galactosyl ceramide-pulsed dendritic cells
2003 StandoutNobel
The cutaneous manifestations of humanparvovirus B19 infection
2000
The biology of human natural killer-cell subsets
2001 Standout
Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
2000
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
1999
The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering
2000
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
2007 Standout
Parvovirus-associated arthritis
2000
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
HLA‐G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex
1997
Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemias
2008
Mesenchymal stem cells in health and disease
2008 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner
1999
NKRP1A molecule is involved in transendothelial migration of CD4+ human T lymphocytes
1997
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
2008 StandoutNature
Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes
2003
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
1998 StandoutNature
Major histocompatibility complex class I‐dependent skewing of the natural killer cell Ly49 receptor reportoire
1996
Symmetry Recognizing Asymmetry
2003 StandoutNobel
The Human Gene Encoding the Lectin-Type Oxidized LDL Receptor (OLR1) Is a Novel Member of the Natural Killer Gene Complex with a Unique Expression Profile
1998 StandoutNobel
The role of natural killer cells in host—parasite interactions
1995
Natural Killer Cells: From No Receptors to Too Many
1997
Parvovirus B19 infection and autoimmune disease
2003
Functions of natural killer cells
2008 Standout
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA‐Cw4 molecules
1997
Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
1995
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells
2000
Interleukin‐15‐induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2‐A as the only HLA class I‐specific inhibitory receptor
1997
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies
1996
The two NF-κB activation pathways and their role in innate and adaptive immunity
2004 Standout
Identification of the rat homologue of the human NKp46 triggering receptor
1999
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
T cell clones expressing the natural killer cell‐related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
1994
Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
1995
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Cloning of a new lectin-like receptor expressed on human NK cells
1999
Screening of Patients With Complex Regional Pain Syndrome for Antecedent Infections
2001
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
1998
Human invariant Vα24+ natural killer T cells activated by α‐galactosylceramide (KRN7000) have cytotoxic anti‐tumour activity through mechanisms distinct from T cells and natural killer cells
2000
Identification of NKp80, a novel triggering molecule expressed by human NK cells
2001
Defining trained immunity and its role in health and disease
2020 Standout
Current perspectives of natural killer cell education by MHC class I molecules
2010
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes
1997
Ex vivo characterization of human thymic dendritic cell subsets
2007 StandoutNobel
Parvovirus B19
2004 Standout
Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection
2001
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
NK CELL RECOGNITION
2004 Standout
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
2002 Standout
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
2009 Standout
X-Linked Lymphoproliferative Disease
2000
Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor
2005
NK CELL RECEPTORS
1998 Standout
Identification of a Common Developmental Pathway for Thymic Natural Killer Cells and Dendritic Cells
1998
The lymphoproliferative defect in CTLA-4–deficient mice is ameliorated by an inhibitory NK cell receptor
2002 StandoutNobel
Regulation of the Natural Killer Cell Receptor Repertoire
2001
Human Parvovirus B19
2002 Standout
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells.
1995
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation
1996
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Peptide Specificity in the Recognition of MHC Class I by Natural Killer Cell Clones
1995 Science
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Functional Requirements for Signaling through the Stimulatory and Inhibitory Mouse NKR-P1 (CD161) NK Cell Receptors
2005
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes
2000 Standout
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Immunobiology of Dendritic Cells
2000 Standout
Decoding the Patterns of Self and Nonself by the Innate Immune System
2002 StandoutScience
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
2001
Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule.
1996
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells
1999
Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
2010 StandoutNobel
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
1994
Identification of a Novel Developmental Stage Marking Lineage Commitment of Progenitor Thymocytes
1997
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
1999
NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis
1998
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
1996
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
1996
Works of Luca Nanni being referenced
Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells
1994
Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A‐mediated regulation of proliferation and cytolytic activity
1996
Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties
1998